Natural killer (NK) cell-based adoptive immunotherapy is a promising treatment approach for
many cancers. However, development of protocols that provide large numbers of functional …

Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment
for many cancers. Such therapeutic application in humans requires large numbers of …

Natural killer (NK) cell-based adoptive immunotherapy is an attractive adjuvant treatment
option for patients with acute myeloid leukemia. Recently, we reported a clinical-grade …

Natural killer (NK) cells are important mediators of anti-tumor immunity and are active
against several hematologic malignancies, including multiple myeloma (MM). Umbilical cord …

Background aims. Natural killer (NK) cell-based adoptive immunotherapy is a promising
approach for the treatment of cancer. Ex vivo expansion and activation of NK cells under …

Natural killer (NK) cells are unique innate lymphoid cells that have therapeutic potential in
adoptive cell transfer-based cancer immunotherapy that has been established across a …

Human natural killer (NK) cell-based adoptive anticancer immunotherapy has gained
intense interest with many clinical trials actively recruiting patients to treat a variety of both …

Simple Summary NK cell anti-tumor activity against hematological malignancies is well-
established and many studies support their role in the control of solid tumor growth and …

Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …

Ex vivo-expanded, allogeneic natural killer (NK) cells can be used for the treatment of
various types of cancer. In allogeneic NK cell therapy, NK cells from healthy donors must be …